TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
UCB Pharma AS
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
224,615
|
244,006
|
256,574 |
Financial expenses |
3,197
|
1,913
|
1,198 |
Earnings before taxes |
5,855
|
7,341
|
8,069 |
Total assets |
146,844
|
133,452
|
138,632 |
Current assets |
146,670
|
133,304
|
138,536 |
Current liabilities |
114,159
|
103,449
|
109,586 |
Equity capital |
32,685
|
30,003
|
29,045 |
- share capital |
489
|
523
|
508 |
Employees (average) | 9 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
22.3%
|
22.5%
|
21.0% |
Turnover per employee | 27,112 | ||
Profit as a percentage of turnover |
2.6%
|
3.0%
|
3.1% |
Return on assets (ROA) |
6.2%
|
6.9%
|
6.7% |
Current ratio |
128.5%
|
128.9%
|
126.4% |
Return on equity (ROE) |
17.9%
|
24.5%
|
27.8% |
Change turnover |
-3,224
|
-20,519
|
-6,876 |
Change turnover % |
-1%
|
-8%
|
-3% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.